DEFUSE 3
Description: DEFUSE 3 is a clinical trial evaluating endovascular thrombectomy for selected patients with acute ischemic stroke treated 6 to 16 hours after onset.
Primary topic: Acute Ischemic Stroke Management (94%)
Related topic: Acute Ischemic Stroke Management (94%)
OpenAlex ID: keywords/defuse-3
